Hussman Strategic Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.95M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.79M | Buy |
|
|||||
|
2024
Q4 | $1.15M | Sell |
|
|||||
|
2024
Q3 | $3.63M | Buy |
|
|||||
|
2024
Q2 | $3.47M | Buy |
|
|||||
|
2024
Q1 | $1.45M | Hold |
|
|||||
|
2023
Q4 | $1.38M | Sell |
|
|||||
|
2023
Q3 | $3.19M | Sell |
|
|||||
|
2023
Q2 | $3.43M | Sell |
|
|||||
|
2023
Q1 | $4.71M | Buy |
|
|||||
|
2022
Q4 | $3.11M | Sell |
|
|||||
|
2022
Q3 | $3.31M | Hold |
|
|||||
|
2022
Q2 | $3.04M | Hold |
|
|||||
|
2022
Q1 | $2.92M | Buy |
|
|||||
|
2021
Q4 | $886K | Sell |
|
|||||
|
2021
Q3 | $1.49M | Hold |
|
|||||
|
2021
Q2 | $1.51M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $962K | Hold |
|
|||||
|
2020
Q2 | $1.22M | Sell |
|
|||||
|
2020
Q1 | $1.3M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $881K | Hold |
|
|||||
|
2018
Q4 | $714K | Buy |
|